SRPT 241220 127.00P (SRPT241220P127000) Stock Options, News & Quotes

US OptionsDetailed Quotes

SRPT241220P127000

Watchlist

8.17
+4.20+105.79%

15min DelayTrading Dec 19 11:39 ET

8.17High8.17Low

Intraday

5D
Daily

News

25 U.S. 'Highest Conviction' Stocks – UBS
Seeking AlphaDec 19 10:48 ET
A Glimpse Into The Expert Outlook On Sarepta Therapeutics Through 15 Analysts
BenzingaDec 19 08:01 ET
Express News | HC Wainwright & Co. Reiterates Sell on Sarepta Therapeutics, Maintains $75 Price Target
BenzingaDec 19 07:19 ET
Express News | Sarepta Therapeutics Inc - Anticipates Filing for Accelerated Approval of Srp-9003 in 2025
ReutersDec 18 08:30 ET
Express News | Sarepta Therapeutics Completes Enrollment in Emergene, a Phase 3 Clinical Study of Srp-9003 for the Treatment of Limb-Girdle Muscular Dystrophy Type 2E/R4
ReutersDec 18 08:30 ET
Sarepta Therapeutics Completes Enrollment in EMERGENE, a Phase 3 Clinical Study of SRP-9003 for the Treatment of Limb-Girdle Muscular Dystrophy Type 2E/R4
Sarepta TherapeuticsDec 18 00:00 ET

Comments

Clintzilla

Nov 26 19:04

$Sarepta Therapeutics (SRPT.US)$ scroll down the feed, do your own DD, not financial advise but Court stuff on youtube and more if you are an "investor" not a penny flipper.. or degenerate gambler can bank off this company but they can save lives with their medicine and big pharm can't stand it but they will breakthrough and make room for LGVN RNAZ and more

Clintzilla

Nov 26 19:03

$Sarepta Therapeutics (SRPT.US)$ short week but i gave the under 110 entry and 140C from down there, still like 140C this week, 160C next week, 200 January

Clintzilla

Nov 26 19:00

$Sarepta Therapeutics (SRPT.US)$ nice

Clintzilla

Nov 14 14:06

$Sarepta Therapeutics (SRPT.US)$ Big Pharm ever backs off, this is probably the Company i believe in the most after following em for a few years, this is worth 300 plus in a 2-3 years or less

Clintzilla

Nov 14 14:04

$Sarepta Therapeutics (SRPT.US)$ i aint checked the pipeline 100 strong psych but can we get 85 before going to 170 again?